FORMYCON AG
🏢 View company profile →5Patents
5Active
5Granted
43Portfolio score
Filing activity: Nov 13, 2014 → Feb 26, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10576128B2 | Liquid formulation of a VEGF antagonist | Chemistry; Metallurgy | 36 | Active |
| US10568951B2 | Pharmaceutical composition of an anti-VEGF antibody | Chemistry; Metallurgy | 5 | Active |
| US10925927B2 | Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist | Chemistry; Metallurgy | 5 | Active |
| US11666632B2 | Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist | Chemistry; Metallurgy | 2 | Active |
| US11298405B2 | Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.